JANE STREET GROUP, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$11,058
-66.9%
23,577
-16.1%
0.00%
Q1 2023$33,454
-18.4%
28,113
+57.1%
0.00%
Q2 2021$41,000
+13.9%
17,892
+37.7%
0.00%
Q1 2021$36,000
+12.5%
12,991
+14.4%
0.00%
Q4 2020$32,000
-42.9%
11,356
-7.9%
0.00%
Q2 2020$56,000
-31.7%
12,332
+20.9%
0.00%
-100.0%
Q2 2014$82,00010,2040.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders